These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10987 related articles for article (PubMed ID: 11448067)

  • 1. Acute effects of stereotactic radiosurgery on the kinetics of glucose metabolism in metastatic brain tumors: FDG PET study.
    Yamamoto T; Nishizawa S; Maruyama I; Yoshida M; Tsuchida T; Waki A; Fujibayashi Y; Kubota T; Yonekura Y; Itoh H
    Ann Nucl Med; 2001 Apr; 15(2):103-9. PubMed ID: 11448067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperacute changes in glucose metabolism of brain tumors after stereotactic radiosurgery: a PET study.
    Maruyama I; Sadato N; Waki A; Tsuchida T; Yoshida M; Fujibayashi Y; Ishii Y; Kubota T; Yonekura Y
    J Nucl Med; 1999 Jul; 40(7):1085-90. PubMed ID: 10405124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
    Herholz K; Rudolf J; Heiss WD
    J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
    Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
    Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
    No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
    Tsuyuguchi N
    Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
    Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y
    Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid
    Yang DM; Palma D; Louie A; Malthaner R; Fortin D; Rodrigues G; Yaremko B; Laba J; Gaede S; Warner A; Inculet R; Lee TY
    J Med Imaging Radiat Oncol; 2019 Feb; 63(1):94-101. PubMed ID: 30281918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling.
    Sugawara Y; Zasadny KR; Grossman HB; Francis IR; Clarke MF; Wahl RL
    Radiology; 1999 Apr; 211(1):249-56. PubMed ID: 10189480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kinetics of glucose metabolism in central neurocytomas].
    Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
    No To Shinkei; 1995 Oct; 47(10):981-7. PubMed ID: 7577144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.
    Chao ST; Suh JH; Raja S; Lee SY; Barnett G
    Int J Cancer; 2001 Jun; 96(3):191-7. PubMed ID: 11410888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
    Kuwabara H; Gjedde A
    J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Although Non-diagnostic Between Necrosis and Recurrence, FDG PET/CT Assists Management of Brain Tumours After Radiosurgery.
    Torrens M; Malamitsi J; Karaiskos P; Valotassiou V; Laspas F; Andreou J; Stergiou C; Prassopoulos V
    In Vivo; 2016; 30(4):513-20. PubMed ID: 27381617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irradiation effects on the metabolism of metastatic brain tumors: analysis by positron emission tomography and 1H-magnetic resonance spectroscopy.
    Yoshino E; Ohmori Y; Imahori Y; Higuchi T; Furuya S; Naruse S; Mori T; Suzuki K; Yamaki T; Ueda S; Tsuzuki T; Takai S
    Stereotact Funct Neurosurg; 1996; 66 Suppl 1():240-59. PubMed ID: 9032867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies.
    Torizuka T; Zasadny KR; Recker B; Wahl RL
    Radiology; 1998 Jun; 207(3):767-74. PubMed ID: 9609902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of semiquantitative FDG-PET in the prediction of brain tumor treatment response to gamma knife radiosurgery.
    Lee JK; Liu RS; Shiang HR; Pan DH
    J Comput Assist Tomogr; 2003; 27(4):525-9. PubMed ID: 12886136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
    Satoh Y; Onishi H; Nambu A; Araki T
    Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
    Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
    J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 550.